GlaxoSmithKline Inc. abandoned its attempt to sell the alli brand and recommitted to promoting the beleaguered OTC weight loss aid, although it continues to drag down consumer health care product sales.
Glaxo Keeps Alli As Recently Pruned Consumer Division Thrives
GlaxoSmithKline abandons its attempt to divest the OTC weight loss aid alli, even though the beleaguered brand continues to drag down consumer division sales. The division’s sales climbed 7% excluding alli in the firm’s second quarter, but only 5% including the product’s results.